Clinical features and efficiency of therapy of schizophrenic patients with risperidone and haloperidol

This study was directed at the comparative study of efficiency of drugs risperidone and haloperidol with identification of significant differences according to parameters of clinical efficiency and safety at inpatient stage. Clinical-psychopathological and psychometrical examination of 60 schizophrenic patients was conducted. Group 1 (30 patients) received risperidone, group 2 (30 patients) received haloperidol. The results of the study of efficiency and safety of risperidone and haloperidol suggest that both medications are antipsychotic drugs of first choice for treatment of group of schizophrenic inpatients. The findings of the research indicate the need for a differentiated approach to administration of these antipsychotics taking into account the forms of schizophrenia and identified psychopathological state of patients.